• Capricor Therapeutics (NASDAQ:CAPR) Receives Buy Rating from HC Wainwright

    Source: Buzz FX / 18 Mar 2025 12:36:17   America/Chicago


    Capricor Therapeutics (NASDAQ:CAPR) Receives Buy Rating from HC Wainwright Written by MarketBeat March 18, 2025 Share Link copied to clipboard. Remove Ads Capricor Therapeutics ( NASDAQ:CAPR - Get Free Report ) 's stock had its "buy" rating
    Read more...
Share on,